Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir with peginterferon alfa-2b and ribavirin in pediatric genotype 1 hepatitis C
2011-004564-30Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of telaprevir in hepatitis C virus infection, sponsored by Vertex Pharmaceuticals. Primary endpoint: Safety. Started Sep 2012; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2011-004564-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004564-30.